Gary C Shaw (Gary Shaw)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Top Venues

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Kavi Fatania, Russell Frood, Marcus Tyyger, Garry McDermott, Sharon Fernandez, Gary C Shaw, Marjorie Boissinot, Daniela Salvatore, Luisa Ottobrini, Irvin Teh, John Wright, Marc A Bailey, Joanna Koch-Paszkowski, Jurgen E Schneider, David L Buckley, Louise Murray, Andrew F Scarsbrook, Susan C Short, Stuart Currie
Exploratory Analysis of Serial 18 F-fluciclovine PET-CT and Multiparametric MRI during Chemoradiation for Glioblastoma. Cancers 14 (14) (2022)
Anke Brüning-Richardson, Gary C Shaw, Daniel Tams, Tim Brend, Hitesh Sanganee, Simon T Barry, Gregory Hamm, Richard J A Goodwin, John G Swales, Henry King, Lynette Steele, Ruth Morton, Anastasia Widyadari, Thomas A Ward, Filomena Esteves, Marjorie Boissinot, Georgia Mavria, Alastair P Droop, Sean E Lawler, Susan C Short
Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13 , 5939. Cancers 14 (15) (2022)
Anke Brüning-Richardson, Gary C Shaw, Daniel Tams, Tim Brend, Hitesh Sanganee, Simon T Barry, Gregory Hamm, Richard J A Goodwin, John G Swales, Henry King, Lynette Steele, Ruth Morton, Anastasia Widyadari, Thomas A Ward, Filomena Esteves, Marjorie Boissinot, Alastair Droop, Sean E Lawler, Susan C Short
GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 13 (23) (2021)
Tereza Andreou, Jennifer Williams, Rebecca J Brownlie, Robert J Salmond, Erica B Wilson, Gary C Shaw, Alan A Melcher, Heiko Wurdak, Susan C Short, Mihaela Lorger
Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model. Journal for immunotherapy of cancer 9 (3) (2021)